| 000 | 01712cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030716.0 | ||
| 008 | 121120s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.12.02.M.Sc.2012.Ah.A | ||
| 100 | 0 | _aAhmed Abdelfattah Mohamed Attallah | |
| 245 | 1 | 0 |
_aAssessment of hepatic fibrosis stages in hepatitis C virus infected patients using biomarkers in the blood / _cAhmed Abdelfattah Mohamed Attallah ; Supervised Sanaa O. Abdallah , Yehia M. Shaker |
| 246 | 1 | 5 | _aتقييم مراحل تليف الكبد فى مرضى مصابون بفيروس الالتهاب الكبدي الوبائي سي باستخدام دلالات حيوية فى الدم |
| 260 |
_aCairo : _bAhmed Abdelfattah Mohamed Attallah , _c2012 |
||
| 300 |
_a145 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry | ||
| 520 | _aLiver biopsy has been useful in providing information on the natural history of the progression of fibrosis. It has also its limitations. Non-invasive alternatives are a must. Serum samples of 382 Egyptian patients with HCV wew included. Fibronectin was purifed from serum samples of liver fibrosis patients showing sharp band at 90 kDa | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aFDS | |
| 653 | 4 | _aFibronectin | |
| 653 | 4 | _aHepatitis C virus | |
| 700 | 0 |
_aSanaa Othman Abdallah , _eSupervisor |
|
| 700 | 0 |
_aYehia Shaker Mohamed Shaker , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40295 _d40295 |
||